646.60
price up icon1.42%   9.04
pre-market  プレマーケット:  650.22   3.62   +0.56%
loading

Argen X Se Adr (ARGX) 最新ニュース

pulisher
Aug 11, 2025

Chronic Inflammatory Demyelinating Polyneuropathy Market Report 2025 | Distribution Channel, Route of Administration, and Region Analysis and Forecast to 2035 - GlobeNewswire Inc.

Aug 11, 2025
pulisher
Aug 09, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - GlobeNewswire Inc.

Aug 09, 2025
pulisher
Aug 08, 2025

argenx ADR Earns Relative Strength Rating Upgrade; Hits Key Benchmark - inkl

Aug 08, 2025
pulisher
Jul 31, 2025

Argenx NV ADR stock reaches all-time high at 689.13 USD By Investing.com - Investing.com South Africa

Jul 31, 2025
pulisher
Jul 31, 2025

Argenx NV ADR stock reaches all-time high at 689.13 USD - Investing.com Nigeria

Jul 31, 2025
pulisher
Jul 31, 2025

argenx ADR earnings beat by $3.26, revenue topped estimates - Investing.com South Africa

Jul 31, 2025
pulisher
Jul 21, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Jul 21, 2025
pulisher
Jul 03, 2025

Morgan Stanley assumes coverage on argenx stock with Overweight rating - Investing.com

Jul 03, 2025
pulisher
Jul 01, 2025

Argenx stock advances as H.C. Wainwright reiterates Buy rating - Investing.com

Jul 01, 2025
pulisher
Jun 30, 2025

Argenx stock falls after FDA flags serious risk signal with Vyvgart - Investing.com

Jun 30, 2025
pulisher
May 22, 2025

argenx SE’s SWOT analysis: biotech stock’s growth potential and challenges - Investing.com

May 22, 2025
pulisher
May 20, 2025

argenx ADR Shows Market Leadership With Jump To 84 RS Rating - Investor's Business Daily

May 20, 2025
pulisher
May 14, 2025

10 Stocks Analysts Are Upgrading Today - Insider Monkey

May 14, 2025
pulisher
May 09, 2025

Argenx Earnings: Vyvgart Delivers Strong Sales Growth; Prefilled Syringe Expands Patient Access - Morningstar

May 09, 2025
pulisher
May 09, 2025

Metric Analysis: Argen X SE ADR (ARGX)’s Key Ratios in the Limelight - DWinneX

May 09, 2025
pulisher
May 09, 2025

Analyzing Ratios: Symbotic Inc (SYM)’s Financial Story Unveiled - DWinneX

May 09, 2025
pulisher
May 08, 2025

Biotech Tumbles. Why Its Sales Beat Wasn't Enough. - Investor's Business Daily

May 08, 2025
pulisher
May 08, 2025

argenx ADR earnings beat by $0.34, revenue topped estimates - Investing.com Nigeria

May 08, 2025
pulisher
May 08, 2025

Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings - Benzinga

May 08, 2025
pulisher
Apr 30, 2025

Argenx Stock Extends Rally In A Base As Earnings Loom - Investor's Business Daily

Apr 30, 2025
pulisher
Apr 14, 2025

argenx ADR Earns Relative Strength Rating Upgrade - inkl

Apr 14, 2025
pulisher
Apr 12, 2025

Argenx stock target holds at $720, H.C. Wainwright affirms Buy rating By Investing.com - Investing.com South Africa

Apr 12, 2025
pulisher
Apr 11, 2025

Biotech Leader Surges On 'Best-Case Scenario' For Key Drug - Investor's Business Daily

Apr 11, 2025
pulisher
Apr 11, 2025

Guggenheim maintains Buy on Argenx stock, target at $1,100 - Investing.com India

Apr 11, 2025
pulisher
Apr 11, 2025

Guggenheim maintains Buy on Argenx stock, target at $1,100 By Investing.com - Investing.com South Africa

Apr 11, 2025
pulisher
Apr 11, 2025

Argenx stock target holds at $720, H.C. Wainwright affirms Buy rating - Investing.com India

Apr 11, 2025
pulisher
Apr 11, 2025

Stifel maintains $780 target on argenx stock after FDA nod - Investing.com

Apr 11, 2025
pulisher
Apr 04, 2025

Stocks To Watch: argenx ADR Sees RS Rating Jump To 91 - Investor's Business Daily

Apr 04, 2025
pulisher
Mar 17, 2025

Bernstein double upgrades Argenx to "outperform," raises price target to €755 By Investing.com - Investing.com South Africa

Mar 17, 2025
pulisher
Mar 17, 2025

Bernstein double upgrades Argenx to "outperform," raises price target to €755 - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

Bernstein raises argenx stock rating, hikes target to EUR755 - Investing.com

Mar 17, 2025
pulisher
Mar 13, 2025

TD Cowen maintains argenx stock with $761 target, bullish outlook - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

TD Cowen maintains argenx stock with $761 target, bullish outlook By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 12, 2025

Deutsche Bank lifts argenx stock rating to hold, sets EUR575 target - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Deutsche Bank lifts argenx stock rating to hold, sets EUR575 target By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 10, 2025

Guggenheim raises argenx stock target to $1,100 on growth outlook - Investing.com India

Mar 10, 2025
pulisher
Mar 07, 2025

argenx SE ADR to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Argenx Publishes Long-Term Data At The American Academy Of Neurology 2025 Annual Meeting - Marketscreener.com

Mar 07, 2025
pulisher
Mar 04, 2025

Why This Biotech Tumbled For A Second Straight Day - Investor's Business Daily

Mar 04, 2025
pulisher
Feb 28, 2025

Argenx Benefits From Multiple Approved Indications of Vyvgart and Strong Uptake - Morningstar

Feb 28, 2025
pulisher
Feb 28, 2025

Argenx's Q4 Sales Backed by Vyvgart's Growth, Oppenheimer Says -February 28, 2025 at 11:05 am EST - Marketscreener.com

Feb 28, 2025
pulisher
Feb 28, 2025

H.C. Wainwright lifts argenx stock price target to $720 By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 28, 2025

H.C. Wainwright lifts argenx stock price target to $720 - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

Argenx stock target raised to $701 by JMP on VYVGART strength - Investing.com South Africa

Feb 28, 2025
biotechnology ONC
$307.51
price up icon 6.74%
$112.78
price up icon 1.60%
$122.87
price up icon 0.71%
$432.52
price up icon 0.60%
$561.55
price up icon 0.90%
大文字化:     |  ボリューム (24 時間):